IL1B and acute respiratory distress syndrome: Recent studies have demonstrated that pretreatment with ALA can ameliorate LPS-induced ALI by not only reducing the release of IL-1β cytokines from apoptosis cells but also inhibiting the activation of Pyrin inflammasome-driven macrophage sepsis [132, 133], offering a potential therapeutic option for managing ALI/ARDS through enteral nutrition.